|
|
40
|
|
|
KEYTRUDA 25MG/ML INJ (MSD/STO) PEMBROLIZUMAB
|
|
|
4ML VIAL
|
|
|
C
|
|
|
9,766.50
|
|
|
25MG/ML
|
|
|
0
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|